Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hepatic encephalopathy/dijareja
Veza se sprema u međuspremnik
Page 1 od 57 rezultati
Hepatic coma induced by high protein therapy and by diarrhea; two case reports.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Production and oxidation of short-chain fatty acids in the human colon: implications for antibiotic-associated diarrhea, ulcerative colitis, colonic cancer, and hepatic encephalopathy.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
A controlled cross-over clinical comparison of lactose (50 g twice a day) versus neomycin (3 g/day) plus milk of magnesia, was carried out in ten cirrhotic patients with chronic portal-systemic encephalopathy and documented lactase deficiency. Serial semiquantitative assessments were done including:
In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Lactose intolerance occurs in the majority of human groups, excluding people from Northern Europe. Because its effect is similar to that of lactulose, lactose seems to be an alternative treatment for patients with portal-systemic encephalopathy (PSE) and lactase deficiency. The mechanism of action
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Irritable bowel syndrome (IBS) is a chronic, functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habit. The pathophysiology is unclear, but may include altered gut motility, visceral hypersensitivity, abnormal central pain processing, chronic low-grade
Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Lactitol (beta-galactosido-sorbitol) has been recently compared with lactulose for the treatment of chronic hepatic encephalopathy in a few studies, each comprising a small number of patients. The results are controversial. We studied the efficiency and tolerance of both compounds by using a
Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND
The most widely used treatment of portal-systemic encephalopathy (PSE) is the administration of oral, non-absorbable disaccharides. Theoretically, the inhibition of intestinal disaccharidases should induce malabsorption of disaccharides and increase delivery of undigested carbohydrates to
Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
OBJECTIVE
The purpose of this study was to assess the incidence of Clostridium difficile infection in patients who received rifaximin for the treatment of hepatic encephalopathy (HE).
METHODS
Medical charts of patients who received rifaximin for the treatment of HE were reviewed. The number of
[Rifaximin for hepatic encephalopathy in children. Case report].
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Rifaximin is an antibiotic recently approved for the treatment of hepatic encephalopathy in adults. In children more than 12 year-old, it has been approved for travelers' diarrhea and it is also widely used in inflammatory bowel disease. We report, to our knowledge, the first case of a pediatric
Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
The nonabsorbed (< 0.4%) oral antibiotic rifaximin, which has been available for enteric bacterial conditions for more than a decade in several countries outside the United States, was recently introduced in the United States for the treatment of travelers' diarrhea, and is being evaluated in
Considerations for the cost-effective management of hepatic encephalopathy.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Hepatic encephalopathy (HE) is a neuropsychiatric complication commonly associated with liver disease, namely cirrhosis. The inability of the liver to metabolize ammonia results in a buildup of ammonia, which can cross the blood-brain barrier and cause significant neurocognitive impairment. Up to
Rhubarb-based Chinese herbal formulae for hepatic encephalopathy: a systematic review and Meta-analysis.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Nightly high dose lactulose infusion could be a cost-effective treatment for hepatic encephalopathy, renal insufficiency and heart failure.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Lactulose is an established remedy for hepatic encephalopathy and shows efficacy for chronic renal insufficiency, reducing volume overload, uremia and hyperkalemia. Potentially lactulose could also be used for non-diuretic treatment of congestive heart failure. However, use of lactulose is limited
Hepatic encephalopathy: a review of its pathophysiology and treatment.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Hepatic encephalopathy (HE) is a broad spectrum of neuropsychiatric manifestations usually affecting individuals with end-stage liver disease. The presence of HE is a poor prognostic sign, with 1-year mortality rates of almost 60%. There is much debate about the underlying mechanisms that result in
Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Patients with cirrhosis commonly experience hepatic encephalopathy (HE), a condition associated with alterations in behavior, cognitive function, consciousness, and neuromuscular function of varying severity. HE occurring before liver transplant can have a substantial negative impact on
Najkompletnija baza ljekovitog bilja potpomognuta naukom
- Radi na 55 jezika
- Biljni lijekovi potpomognuti naukom
- Prepoznavanje biljaka po slici
- Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
- Pročitajte naučne publikacije povezane sa vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima
